FindTrial
Sign In

A real-world study of the impact of mNGS detection of BALF on the diagnosis and clinical outcome of severe pneumonia

A real-world study of the impact of mNGS detection of BALF on the diagnosis and clinical outcome of severe pneumonia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061251
Enrollment
Unknown
Registered
2022-06-18
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Pneumonia

Interventions

Group 1 :
Group 2:

Sponsors

Henan Provincial People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with severe pneumonia admitted to each central hospital during the study period; 2. Bronchoscopy can be completed within 48-72 hours of enrollment; 3. Age >= 18 years old; 4. The patient or his legal representative signs the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with active pulmonary tuberculosis or undergoing anti-tuberculosis treatment; 2. HIV/AIDS; 3. Pregnant women and lactating women; 4. Patients with recurrent VAP.

Design outcomes

Primary

MeasureTime frame
30 days mortality;—

Countries

China

Contacts

Public ContactXiaoju Zhang

Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital

15837101166@163.com+86 15837101166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026